Apellis Pharmaceuticals shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $26M | 16M | 1.63 |
| 2023-09-30 | $15M | 12M | 1.26 |
| 2023-06-30 | $34M | 14M | 2.40 |
| 2023-03-31 | $33M | 17M | 1.87 |
| 2022-12-31 | $32M | 20M | 1.54 |
| 2022-09-30 | $28M | 15M | 1.95 |
| 2022-06-30 | $11M | 7.6M | 1.50 |
| 2022-03-31 | $16M | 10M | 1.59 |
| 2021-12-31 | $23M | 15M | 1.52 |
| 2021-06-30 | $26M | 14M | 1.85 |
| 2020-12-31 | $38M | 23M | 1.69 |
| 2020-09-30 | $23M | 22M | 1.07 |